Today: 21 May 2026
Citigroup stock slips ahead of Jan. 14 earnings as bank season nears
8 January 2026
1 min read

Citigroup stock slips ahead of Jan. 14 earnings as bank season nears

NEW YORK, January 7, 2026, 21:07 EST — Market closed

  • Citigroup shares fell 0.9% to $121.37 in the latest session, after trading as low as $120.72.
  • Citi reports fourth-quarter results on Jan. 14, with investors focused on trading and investment banking fees.
  • Traders are also watching Friday’s U.S. payrolls report and early bank earnings for direction on rate bets.

Citigroup Inc shares eased on Wednesday, with the stock last down 0.9% at $121.37. The session ranged from $120.72 to $122.81 as traders squared positions into next week’s bank earnings run.

The timing matters because big U.S. lenders start reporting on Jan. 13, and Citi is in the first wave a day later alongside peers including Bank of America and Wells Fargo. Analysts expect stronger capital-markets activity to lift earnings per share (EPS) — a common profit measure — and Dealogic data show global investment banking revenue rose 15% in 2025 while mergers and acquisitions (M&A) volume jumped 42%. “The fourth quarter shaped up to be a perfect recipe in the consecutive buildup for investment banking revenues,” said Stephen Biggar, a banking analyst at Argus Research, while Morningstar analyst Sean Dunlop said inflation is “the biggest variable” heading into the new year. Reuters

Citi said it will issue results at about 8 a.m. ET on Wednesday, Jan. 14, and review them at 11 a.m. ET on a webcast and conference call. Investors are likely to press for details on expenses, capital and any hints on the pace of buybacks once results and capital levels are in hand.

The broader tape was choppy on Wednesday, and financials were a drag, with the S&P 500 financials index down 1.4% while JPMorgan slid after a Wolfe Research downgrade. Data showing U.S. job openings fell more than expected and a softer private payrolls print kept attention on Friday’s government jobs report.

For Citi specifically, traders will parse net interest margin — the spread between what a bank earns on loans and pays on deposits — for signs the rate backdrop is turning from headwind to help. They will also watch markets revenue for any drop-off after a strong stretch for trading, and look for clear language on credit costs.

Wednesday’s pullback left Citi sitting close to where it started the week, and the intraday low has become an obvious line for short-term traders. A push back toward the session high would signal the market is willing to pay up ahead of the print, not wait for it.

But the bar is rising. A Reuters column this week flagged lofty U.S. equity valuations as a risk if earnings season fails to justify the optimism priced into stocks, and banks are not immune if fee momentum cools or credit costs surprise to the upside.

Next up is Friday’s payrolls report, then the first big bank numbers next week starting with JPMorgan on Jan. 13. Citi reports a day later.

Stock Market Today

  • Sharda Cropchem Earnings Reveal Weak Cash Flow Despite Profit Growth
    May 20, 2026, 9:35 PM EDT. Sharda Cropchem Limited's (NSE:SHARDACROP) recent earnings report shows a statutory profit of ₹6.81 billion for the year ending March 2026, but free cash flow was significantly lower at ₹1.6 billion, resulting in a high accrual ratio of 0.23. This suggests the company's cash conversion is less than ideal, raising concerns about the sustainability of its earnings. Despite this, Sharda Cropchem's earnings per share (EPS) has grown impressively over the past three years. Investors remain cautious due to three warning signs surrounding the stock, with one marked as significant. The gap between profit and cash flow indicates that reported profits may overstate the company's underlying earning power.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Wall Street jolted by Trump buyback, home-buying moves; S&P 500 slips, Nasdaq steadied by AI
Previous Story

Wall Street jolted by Trump buyback, home-buying moves; S&P 500 slips, Nasdaq steadied by AI

CapitaLand Investment stock climbs after S$260 million Singapore automated logistics bet
Next Story

CapitaLand Investment stock climbs after S$260 million Singapore automated logistics bet

Go toTop